Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes

D Sivakumaran, S Jenum, M Vaz, S Selvam… - Communications …, 2020 - nature.com
signatures predicting 6-month treatment outcome (TB cure vs. treatment failure) and baseline
signatures predicting 2-month treatment outcome (early responders vs. late responders/non…

Host blood RNA transcript and protein signatures for sputum-independent diagnostics of tuberculosis in adults

D Sivakumaran, C Ritz, JE Gjøen, M Vaz… - Frontiers in …, 2021 - frontiersin.org
… The third 58-gene set included type 1-interferon-inducible genes (21) known to be up-regulated
in adult TB and genes associated with prediction of TB risk in South African neonates (29…

[HTML][HTML] Host blood transcriptional signatures as candidate biomarkers for predicting progression to active tuberculosis

CH Kim, G Choi, J Lee - Tuberculosis and Respiratory Diseases, 2023 - ncbi.nlm.nih.gov
… In particular, several mRNA signatures identified in blood transcriptomic studies have …
host blood transcriptional signatures to identify predictive biomarkers for the progression to TB

A 10-gene biosignature of tuberculosis treatment monitoring and treatment outcome prediction

NP Long, NK Phat, NTH Yen, S Park, Y Park, YS Cho… - Tuberculosis, 2021 - Elsevier
… The signature could also be applied for tuberculosis … Screening a 371-gene biosignature
from patients’ blood samples with … host-derived biomarkers in predicting tuberculosis treatment

Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis

H Mulenga, CZ Zauchenberger, EW Bunyasi… - PLoS …, 2020 - journals.plos.org
… of host blood transcriptomic signatures for diagnosis of and prediction of progression to
Tuberculosis disease… host blood mRNA signatures for diagnosis of or prediction of progression to …

Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment

CLR van Doorn, C Eckold, K Ronacher, R Ruslami… - …, 2022 - thelancet.com
… current study was to identify a blood transcriptional gene signature to predict TB treatment
Host gene biomarker profiles to identify TB treatment success or failure could facilitate the …

Reprogramming of small noncoding RNA populations in peripheral blood reveals host biomarkers for latent and active Mycobacterium tuberculosis infection

LS de Araujo, M Ribeiro-Alves, T Leal-Calvo, J Leung… - MBio, 2019 - Am Soc Microbiol
… determined for the TB group was 84.2% (SD, 17.2), and the lowest predicted probability was
… Of note, all 4 members of the TB signature constitute highly accurate individual biomarkers …

Blood RNA signatures predict recent tuberculosis exposure in mice, macaques and humans

RC Ault, CA Headley, AE Hare, BJ Carruthers… - Scientific Reports, 2020 - nature.com
… While several published studies have made genome-scale measurements of the in vivo
host response to M.tb at several time points in mice 27,28,29 , none have addressed the …

Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures

H Warsinske, R Vashisht, P Khatri - PLoS medicine, 2019 - journals.plos.org
… Finally, 7 of 16 gene signatures predicted progression from LTBI to ATB 6 months prior to
sputum conversion with positive predictive value > 6% at 2% prevalence. Our analyses may …

A transcriptional blood signature distinguishes early tuberculosis disease from latent tuberculosis infection and uninfected individuals in a Vietnamese cohort

J Ho, NJ Bokil, PTB Nguyen, TA Nguyen, MY Liu… - Journal of Infection, 2020 - Elsevier
… This binary predicted result was then compared to the observed case or control status to …
the activation of these components of host immunity in early TB disease. Of note however, the …